Correction for: Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells

Aging (Albany NY). 2022 Apr 14;14(7):3329-3330. doi: 10.18632/aging.204017. Epub 2022 Apr 14.

Shushi Huang^{1

2}, Wu Luo^{1

3}, Gaojun Wu², Qirui Shen¹, Zaishou Zhuang³, Daona Yang³, Jinfu Qian¹, Xiang Hu⁴, Yan Cai³, Nipon Chattipakorn⁵, Weijian Huang², Guang Liang^{1

3

6}

¹ Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
² Department of Cardiology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
³ Affiliated Cangnan Hospital, Wenzhou Medical University, Cangnan, Zhejiang, 325000, China.
⁴ Department of Endocrinology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
⁵ Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
⁶ School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China.

No abstract available

Keywords: CDK9; atherosclerosis; inflammation; pharmacological inhibition; phenotypic switching; vascular smooth muscle cells.

Publication types